Recently, Lepu Medical (Beijing) Technology Co., Ltd. successfully obtained the medical device registration certificate (Certificate No.: 国械注准20243031479) issued by the National Medical Products Administration (NMPA) for its “RECATCHOR Exchange Device.” This product, designed for anchoring guidewires and assisting microcatheter exchanges, is now ready to enter the market, benefiting numerous patients.
The product is designed for percutaneous coronary intervention (PCI), where it stabilizes the guidewire within the guiding catheter by balloon inflation, allowing for smooth catheter exchanges.
● Ultra-thin Diameter: The anchoring balloon has a diameter of only 0.65mm (significantly smaller than the approximate 0.85mm diameter of a standard PTCA balloon), ensuring easy compatibility with various single-lumen and dual-lumen microcatheters within a 6F guiding catheter.
● Precision Positioning: The metal marker at the distal end of the anchoring balloon provides clear visibility, ensuring precise positioning within the guiding catheter.
● Safety and Reliability: Even when the entire anchoring balloon catheter is inserted into the guiding catheter, the balloon’s distal end does not extend beyond the guiding catheter, reducing the risk of vascular injury.
● Convenient Operation: The catheter can be delivered without relying on a guidewire, avoiding the complexity associated with PTCA balloon systems that depend on guidewires, thus significantly reducing procedure time and enhancing operational convenience.
The launch of the RECATCHOR Exchange Device marks another milestone in Lepu Medical’s cardiovascular interventional product portfolio. It provides a safe and convenient solution for stabilizing guidewires within guiding catheters, preventing unintended guidewire movement during microcatheter exchanges, and offering clinicians an innovative and reliable tool for their procedures.